Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
14186 | 786 | 48.2 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
207 | 3 | MULTIPLE SCLEROSIS//MYASTHENIA GRAVIS//MULTIPLE SCLEROSIS JOURNAL | 52279 |
58 | 2 | MULTIPLE SCLEROSIS//MULTIPLE SCLEROSIS JOURNAL//NEUROMYELITIS OPTICA | 29459 |
14186 | 1 | GLATIRAMER ACETATE//PROTECTIVE AUTOIMMUNITY//COPOLYMER 1 | 786 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GLATIRAMER ACETATE | authKW | 1521882 | 17% | 30% | 131 |
2 | PROTECTIVE AUTOIMMUNITY | authKW | 1071186 | 5% | 77% | 36 |
3 | COPOLYMER 1 | authKW | 501209 | 3% | 56% | 23 |
4 | COPAXONE | authKW | 388457 | 3% | 50% | 20 |
5 | COPAXONE R | authKW | 386185 | 2% | 76% | 13 |
6 | GLATIRAMER ACETATE GA | authKW | 262217 | 1% | 75% | 9 |
7 | FACIAL NERVE AXOTOMY | authKW | 205149 | 2% | 41% | 13 |
8 | A91 | authKW | 161864 | 1% | 83% | 5 |
9 | NEUROIMMUNE REGULAT | address | 155391 | 1% | 100% | 4 |
10 | BENEFICIAL AUTOIMMUNITY | authKW | 116543 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 4690 | 45% | 0% | 355 |
2 | Immunology | 4283 | 36% | 0% | 282 |
3 | Clinical Neurology | 1752 | 22% | 0% | 169 |
4 | Medicine, Research & Experimental | 98 | 5% | 0% | 42 |
5 | Cell Biology | 57 | 6% | 0% | 51 |
6 | Pharmacology & Pharmacy | 47 | 7% | 0% | 57 |
7 | Pathology | 43 | 3% | 0% | 22 |
8 | Rehabilitation | 34 | 2% | 0% | 14 |
9 | Ophthalmology | 24 | 2% | 0% | 17 |
10 | Allergy | 17 | 1% | 0% | 7 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEUROIMMUNE REGULAT | 155391 | 1% | 100% | 4 |
2 | BEHAV NEUROIMMUNOL | 103591 | 1% | 67% | 4 |
3 | BRAIN IMMUNOL GLIA | 88783 | 1% | 29% | 8 |
4 | CLIN EXPT SPINAL CORD INJURY NEUROPAR LEGI | 77695 | 0% | 100% | 2 |
5 | NEUROL WEXNER MED | 77695 | 0% | 100% | 2 |
6 | SPINAL CORD INJURY 128 | 77695 | 0% | 100% | 2 |
7 | CLIN NEUROIMMUNOL | 68735 | 3% | 7% | 25 |
8 | INVEST CIENCIAS SALUD CICSA | 51796 | 0% | 67% | 2 |
9 | BRAIN IMMUNOL GLIA BIG | 43700 | 0% | 38% | 3 |
10 | BEIT LEV EIN HOSP | 38848 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NEUROIMMUNOLOGY | 40758 | 11% | 1% | 84 |
2 | BRAIN BEHAVIOR AND IMMUNITY | 11572 | 3% | 1% | 27 |
3 | MULTIPLE SCLEROSIS | 6942 | 1% | 2% | 10 |
4 | MULTIPLE SCLEROSIS JOURNAL | 4224 | 2% | 1% | 16 |
5 | TRENDS IN IMMUNOLOGY | 1913 | 1% | 1% | 8 |
6 | CLINICAL IMMUNOLOGY | 1437 | 1% | 0% | 10 |
7 | JOURNAL OF NEUROLOGY | 1232 | 2% | 0% | 14 |
8 | JOURNAL OF THE NEUROLOGICAL SCIENCES | 1087 | 2% | 0% | 17 |
9 | JOURNAL OF NEUROIMMUNE PHARMACOLOGY | 999 | 1% | 1% | 4 |
10 | TRENDS IN MOLECULAR MEDICINE | 780 | 1% | 0% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GLATIRAMER ACETATE | 1521882 | 17% | 30% | 131 | Search GLATIRAMER+ACETATE | Search GLATIRAMER+ACETATE |
2 | PROTECTIVE AUTOIMMUNITY | 1071186 | 5% | 77% | 36 | Search PROTECTIVE+AUTOIMMUNITY | Search PROTECTIVE+AUTOIMMUNITY |
3 | COPOLYMER 1 | 501209 | 3% | 56% | 23 | Search COPOLYMER+1 | Search COPOLYMER+1 |
4 | COPAXONE | 388457 | 3% | 50% | 20 | Search COPAXONE | Search COPAXONE |
5 | COPAXONE R | 386185 | 2% | 76% | 13 | Search COPAXONE+R | Search COPAXONE+R |
6 | GLATIRAMER ACETATE GA | 262217 | 1% | 75% | 9 | Search GLATIRAMER+ACETATE+GA | Search GLATIRAMER+ACETATE+GA |
7 | FACIAL NERVE AXOTOMY | 205149 | 2% | 41% | 13 | Search FACIAL+NERVE+AXOTOMY | Search FACIAL+NERVE+AXOTOMY |
8 | A91 | 161864 | 1% | 83% | 5 | Search A91 | Search A91 |
9 | BENEFICIAL AUTOIMMUNITY | 116543 | 0% | 100% | 3 | Search BENEFICIAL+AUTOIMMUNITY | Search BENEFICIAL+AUTOIMMUNITY |
10 | GLATIRAMOID | 116543 | 0% | 100% | 3 | Search GLATIRAMOID | Search GLATIRAMOID |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LALIVE, PH , NEUHAUS, O , BENKHOUCHA, M , BURGER, D , HOHLFELD, R , ZAMVIL, SS , WEBER, MS , (2011) GLATIRAMER ACETATE IN THE TREATMENT OF MULTIPLE SCLEROSIS EMERGING CONCEPTS REGARDING ITS MECHANISM OF ACTION.CNS DRUGS. VOL. 25. ISSUE 5. P. 401-414 | 64 | 67% | 51 |
2 | ZIEMSSEN, T , SCHREMPF, W , (2007) GLATIRAMER ACETATE: MECHANISMS OF ACTION IN MULTIPLE SCLEROSIS.NEUROBIOLOGY OF MULTIPLE SCLEROSIS. VOL. 79. ISSUE . P. 537-570 | 73 | 68% | 41 |
3 | FARINA, C , WEBER, MS , MEINL, E , WEKERLE, H , HOHLFELD, R , (2005) GLATIRAMER ACETATE IN MULTIPLE SCLEROSIS: UPDATE ON POTENTIAL MECHANISMS OF ACTION.LANCET NEUROLOGY. VOL. 4. ISSUE 9. P. 567 -575 | 56 | 80% | 78 |
4 | WEBER, MS , HOHLFELD, R , ZAMVIL, SS , (2007) MECHANISM OF ACTION OF GLATIRAMER ACETATE IN TREATMENT OF MULTIPLE SCLEROSIS.NEUROTHERAPEUTICS. VOL. 4. ISSUE 4. P. 647-653 | 49 | 75% | 49 |
5 | AHARONI, R , (2013) THE MECHANISM OF ACTION OF GLATIRAMER ACETATE IN MULTIPLE SCLEROSIS AND BEYOND.AUTOIMMUNITY REVIEWS. VOL. 12. ISSUE 5. P. 543-553 | 48 | 59% | 38 |
6 | JOHNSON, KP , (2012) GLATIRAMER ACETATE FOR TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS.EXPERT REVIEW OF NEUROTHERAPEUTICS. VOL. 12. ISSUE 4. P. 371-384 | 59 | 50% | 23 |
7 | SCHWARTZ, M , RAPOSO, C , (2014) PROTECTIVE AUTOIMMUNITY: A UNIFYING MODEL FOR THE IMMUNE NETWORK INVOLVED IN CNS REPAIR.NEUROSCIENTIST. VOL. 20. ISSUE 4. P. 343 -358 | 59 | 45% | 16 |
8 | ARNON, R , SELA, M , (2003) IMMUNOMODULATION BY THE COPOLYMER GLATIRAMER ACETATE.JOURNAL OF MOLECULAR RECOGNITION. VOL. 16. ISSUE 6. P. 412-421 | 43 | 81% | 45 |
9 | SCHWARTZ, M , BARUCH, K , (2014) BREAKING PERIPHERAL IMMUNE TOLERANCE TO CNS ANTIGENS IN NEURODEGENERATIVE DISEASES: BOOSTING AUTOIMMUNITY TO FIGHT-OFF CHRONIC NEUROINFLAMMATION.JOURNAL OF AUTOIMMUNITY. VOL. 54. ISSUE . P. 8 -14 | 47 | 52% | 17 |
10 | AHARONI, R , (2014) IMMUNOMODULATION NEUROPROTECTION AND REMYELINATION - THE FUNDAMENTAL THERAPEUTIC EFFECTS OF GLATIRAMER ACETATE: A CRITICAL REVIEW.JOURNAL OF AUTOIMMUNITY. VOL. 54. ISSUE . P. 81 -92 | 55 | 44% | 16 |
Classes with closest relation at Level 1 |